Fani Karagianni

Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma

Fani Karagianni, Christina Piperi, Vassiliki Mpakou et al. · PLoS ONE · 2021 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

Prediction of Melanoma Risk in a Southern European Population Based on a Weighted Genetic Risk Score

Katerina Kypreou, Irene Stefanaki, Kyriaki Antonopoulou et al. · Journal of Investigative Dermatology · 2015 · 26 citations · Full text

Life Sciences, Genetics, Oncology +16

Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma

Fani Karagianni, Christina Piperi, Berta Casar et al. · Cancers · 2022 · 20 citations · Full text

Medicine, Oncology, Pharmacology +13

Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports

Kyriaki Lampadaki, Marios Koumourtzis, Fani Karagianni et al. · Advances in Therapy · 2021 · 18 citations · Full text

Medicine, Dermatology, Oncology +16

Transgelin Up-Regulation in Obstructive Nephropathy

Fani Karagianni, Niki Prakoura, Garyfallia Kaltsa et al. · PLoS ONE · 2013 · 16 citations · Full text

Medicine, Molecular Biology, Pathology +16